Treatment Considerations for Specific Populations With HR+/HER2- Metastatic Breast Cancer


December 7, 2023 @ 2:15 pm 3:15 pm CST

Presented by Pfizer Oncology

Program Description

Join Dr. Massimo Cristofanilli and Dr. Sramila Aithal at this industry-sponsored program which will review treatment considerations for specific patient populations with HR+/HER2- mBC. Additional patient perspectives will be provided by Patient Ambassador Laurie N. during the program, which is scheduled on Thursday, December 7th, 2023, from 2:15-3:15 PM CT. This Product Theater is a promotional activity and is not approved for continuing education credit.

This Exhibitor Product Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Product Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS).

Massimo Cristofanilli, MD, FACP
Professor of Medicine & Chief of Breast Cancer Oncology
Weill Cornell Medicine

Sramila Aithal, MD
Medical Oncologist/Hematologist
Alliance Cancer Specialists

Laurie N.
Patient Ambassador